Just A Product, Not A Pathway, FDA Says Of Omnitrope Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Sandoz' follow-on human growth hormone does not establish a precedent for follow-on proteins for biologics regulated under the Public Health Service Act.